Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
51 studies found for:    v212
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Comparator: Zostavax™;   Biological: Comparator: Placebo;   Other: VZV Skin Test;   Other: Saline
2 Completed A Study of an Investigational V212/Heat-Treated VZV Vaccine in Immunocompromised Adults (V212-002)(COMPLETED)
Conditions: Herpes Zoster;   Herpes Zoster-related Complications
Interventions: Biological: Comparator: V212;   Biological: Comparator: Placebo
3 Completed A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Placebo
4 Recruiting A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Placebo
5 Active, not recruiting A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (Study No. V212-001 AM4)
Condition: Herpes Zoster
Interventions: Biological: V212;   Biological: Matching placebo
6 Completed A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With HM Receiving Treatment With Anti-CD20 Monoclonal Antibodies (V212-013)
Condition: Herpes Zoster
Intervention: Biological: V212
7 Withdrawn A Lot-to-Lot Consistency Study to Evaluate Safety, Tolerability, and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Healthy Adults (V212-014)
Condition: Herpes Zoster
Interventions: Biological: V212 Lot 1;   Biological: V212 Lot 2;   Biological: V212 Lot 3
8 Completed A Study to Test the Safety and Antibody Response of V212 in Healthy Adults (V212-004)(COMPLETED)
Conditions: Herpes Zoster;   Shingles
Interventions: Biological: Comparator: V212;   Biological: Comparator: Placebo
9 Recruiting V.A.C. VeraFlo™ Instillation Therapy vs V.A.C. Ulta™ Therapy on Biofilm in Chronically Infected Wounds
Conditions: Lower Extremity Wound Infected;   Venous Stasis Ulcers
Interventions: Device: VAC VeraFlo with Dakins Instillation;   Device: VAC Ulta Therapy
10 Recruiting Probiotic Use in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT) - A Pilot Study
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Dietary Supplement: Lactobacillus plantarum strains 299 and 299v
11 Recruiting NY-ESO-1 Vaccine in Combination With Ipilimumab in Patients With Unresectable or Metastatic Melanoma
Condition: Unresectable or Metastatic Melanoma
Interventions: Biological: Ipilimumab;   Biological: NY-ESO-1 Protein Vaccine;   Biological: NY-ESO-1 OLP4 Vaccine
12 Active, not recruiting A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain
Condition: Endometriosis
Interventions: Drug: ASP1707;   Drug: Placebo;   Drug: Leuprorelin acetate
13 Recruiting Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.
Condition: Influenza Virus
Interventions: Biological: Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV);   Biological: Non-adjuvanted Trivalent Influenza Vaccine (TIV) / Quadrivalent Influenza Vaccine (QIV)
14 Unknown  Second Line Therapy to Treat Age-Related Macular Degeneration (AMD) for Patients Not Responding Well to Lucentis Therapy by Itself
Condition: Age Related Macular Degeneration
Interventions: Drug: Visudyne;   Drug: Lucentis;   Drug: Dexamethasone
15 Completed A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.
Condition: Patients With Metabolic Syndrome
Interventions: Drug: Fenofibrate /Metformin;   Drug: Placebo
16 Not yet recruiting An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma
Condition: Childhood Ependymoma
Interventions: Drug: 16 weeks of VEC + CDDP;   Drug: VEC + HD-MTX;   Drug: Chemotherapy + Valproate;   Radiation: Conformal radiotherapy;   Drug: VEC;   Drug: Chemotherapy;   Radiation: conformal radiotherapy +/- boost
17 Completed
Has Results
Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment
Condition: Atrial Fibrillation
Intervention:
18 Recruiting Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: external beam radiation therapy;   Radiation: brachytherapy;   Behavioral: questionnaires
19 Active, not recruiting Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone furoate/vilanterol;   Drug: fluticasone furoate;   Drug: vilanterol;   Other: Placebo
20 Recruiting PET Imaging of Patients With Melanoma and Malignant Brain Tumors Using an 124I-labeled cRGDY Silica Nanomolecular Particle Tracer: A Microdosing Study
Conditions: Newly Diagnosed or Recurrent Metastatic Melanoma Patients;   Malignant Brain Tumors
Intervention: Drug: PET scan with 124I-cRGDY-PEG-dots

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years